Daily stock market tips for RCOM, RELCAP and VIPIND

RCOM

(Cash & Future)

Intraday 86-84-83 and Position 82-77

Just watch these targets below 91…!

(Sell and Sell and Sell at opening …!

Your Stoploss 91.5

Best selling levels 89-90-91

VIPIND

(Trade is Risky and Profit is heavy)

Selling pressure expected 895-801

(Worth is over and bulls will go away from this stock)

Intraday Expected Targets 772-757

Short term targets 720-743 after closing below 780

RELCAP

Last closed 512

Just watch 508 below…!

(Breaking and trading below this level…Stock will crach to 496-492 intraday)

Hold all your short position if closing 500 below for Positional Targets 489 and 464-444 this month

Opening Bell…!

TATAMOTORS

Sell and sell and sell at opening…!

Intraday Targets 1019-1009

(Best selling levels 1056-1050 and Stoploss 1062)

To become a subscriber, subscribe to our free newsletter services. Our service is free for all.

Get free important share market ideas on stocks & nifty tips chart setups, analysis for the upcoming session, and more by joining the below link: Stock Tips

Have you any questions/feedback about this article? Please leave your queries in the comment box for answers.

Disclaimer: The information provided on this website, including but not limited to stock, commodity, and forex trading tips, technical analysis, and research reports, is solely for educational and informational purposes. It should not be considered as financial advice or a recommendation to engage in any trading activity. Trading in stocks, commodities, and forex involves substantial risks, and you should carefully consider your financial situation and consult with a professional advisor before making any trading decisions. Moneymunch.com and its authors do not guarantee the accuracy, completeness, or reliability of the information provided, and shall not be held responsible for any losses or damages incurred as a result of using or relying on such information. Trading in the financial markets is subject to market risks, and past performance is not indicative of future results. By accessing and using this website, you acknowledge and agree to the terms of this disclaimer.